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ABSTRACT
Background. Type 2 diabetes mellitus (T2DM) patients 
experience higher atherothrombotic risks that could lead 
to cardiovascular diseases, due to increases in coagula-
tion activities. The role of exercise in altering coagulation 
activities among T2DM patients is still inconclusive.
This feasibility study aimed to evaluate the immediate 
effect of a moderate intensity ergocycle exercise, pri-
mary on the coagulation parameters and secondary 
on the systemic inflammation and blood glucose, in 
otherwise healthy T2DM patients.
Methods. Ten T2DM patients (64 ± 7 year, 40% female) 
performed a 30-minute moderate-intensity ergocycle 
exercise at 50–60% of heart rate reserved. Coagulation 
parameters (activated partial thromboplastin time 
[aPTT], prothrombin time [PT] and platelet count), 
erythrocyte sedimentation rate, and blood glucose 
were assessed before the exercise (T0), immediately 
after the exercise (T1), and 30 minutes post exercise 
(T2). One-way repeated measured ANOVA was used to 
assess the outcomes over time. 
Results. All participants completed and adhered to the 
exercise protocol. There were increases in aPTT and PT 
but decreases in platelet count at T1 and T2 compared 
to at T0 (P < 0.05), indicating reduction in the coagula-
tion activities. Those values, however, were still within 
normal ranges. The erythrocyte sedimentation rates 
were unaffected, while blood glucose decreased from 
202 ± 35 mg/dL at T0 to 173 ± 33 mg/dL and 158 ± 
30 mg/dL at T1 and T2 (P < 0.01). 
Conclusion. The 30-minute moderate-intensity ergocy-
cle decreases coagulation activities and blood glucose 
but does not affect erythrocyte sedimentation rates 
in T2DM patients. Future studies should focus on the 
chronic adaptation of the coagulation parameters 
after ergocycle training among a T2DM patients with 
coagulation impairments. (Clin Diabetol 2020; 9)
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Introduction
Type 2 diabetes mellitus (T2DM) patients are at 
significant risk of developing cardiovascular disease 
due to the impact of blood glucose elevation on the 
coagulation system, through a series of actions [1]. First, 
the increase of blood glucose could induce endothelial 
abnormalities and stimulate incomplete activation of the 
coagulation cascade [2]. Second, it causes glycation of 
proteins responsible for coagulation activities favouring 
hypercoagulation and stimulates pro-thrombotic states 
[3, 4]. Accumulatively, these events trigger the develop-
ment of atherosclerotic lesions and occlusive thrombus 
which contribute to the pathogenesis of cardiovascular 
diseases such as ischemic heart disease and stroke [5]. 
Thus, hypercoagulation in T2DM patients should be 
monitored and controlled. 
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Among the standard coagulation screening tests 
for monitoring hypercoagulation conditions in T2DM 
patients there are the activated partial thromboplastin 
time (aPTT), prothrombin time (PT) and platelet count 
performed [6]. The aPTT is used to assess the intrinsic 
and common coagulation pathway, while the PT assess-
es the coagulation pathway initiated by tissue factor, 
as well as the common pathway [7]. A prolonged aPTT 
and PT is a clinical indicator of fibrinolytic tendency, 
while a shortened aPTT and PT reflects hypercoag-
ulation conditions [8]. Shortened aPTT and PT have 
been widely reported among T2DM patients [3, 9], 
along with increases in platelet activities [10]. These 
indicators, thus, are used for assessing and monitoring 
hypercoagulation among T2DM patients. 
Exercise may play pivotal roles in altering coag-
ulation activities [11, 12]. Evidence in the literature 
shows that exercise could increase both blood coag-
ulation and fibrinolysis activities, which each causes 
opposite effects on the coagulation tendency [11]. 
The final effect of exercise may depend on the subject 
characteristics and exercise protocols [13]. In such, 
the effect of exercise may differ among different 
age groups or comorbidities and among different 
exercise intensities, types and duration. Specifically, 
transient hypercoagulation has been reported after 
an acute and strenuous exercise in individuals with 
coronary heart disease symptoms [12] and individ-
uals with type 1 diabetes mellitus [11]. In contrast, 
increases in fibrinolytic activities were also reported 
among healthy individuals immediately after vigorous 
exercise [14], thus offer some protection against the 
risk of thrombosis and adverse cardiovascular events. 
These findings, however, may not be readily applied 
for T2DM patients, since these studies have been 
conducted in non-T2DM population and were based 
on vigorous-intensity exercise. Moreover, vigorous 
type of exercise is not recommended among T2DM 
patients and that the current physical activity recom-
mendation for T2DM patients calls for a moderate 
intensity of exercise. 
The heterogeneity of findings of the roles of exer-
cise in altering coagulation activities in the literature, 
thus, substantiate the importance of studying the 
effect of moderate-intensity exercise on coagulation 
parameters. The ergocycle-based exercise was select-
ed in this present study because stationary bicycling 
is one of the exercise types that is recommended for 
T2DM patients [16]. Thus, the primary aim of this 
study was to evaluate the feasibility and immediate 
effect of the moderate-intensity ergocycle exercise on 
the coagulation parameters, in a view to utilizing the 
exercise for improving hypercoagulation conditions in 
T2DM patients. The secondary aim was to study the 
immediate effects of the ergocycle exercise on systemic 
inflammation and blood glucose levels. 
Methods
Participants 
Ten otherwise healthy T2DM patients participated 
in this feasibility study. Patients were recruited from 
a public hospital in Yogyakarta Indonesia where they 
received regular care and diabetes medications from 
their physicians. They obtained clearance from their 
physicians to do regular exercise and participated in this 
study. At least three days prior to the commencement 
of the study, they were required to refrain from having 
performed any type of heavy physical activity. 
Procedures and ethical clearance
The procedures used in this study were approved 
by the Ethics Committee of the Faculty of Medicine of 
Gadjah Mada University (KE/0565). Written informed 
consent was obtained from each participant. Partici-
pants were required to perform a warm-up exercise 
routine for ten minutes before the ergocycle exercise 
sessions. The warm-up exercise comprised flexibility 
exercises involving upper and lower extremities joints. 
The participants then were required to exercise on a 
bicycle ergometer to achieve free pedaling at work-
load up to two kilopounds (kp) until they established 
a regular and steady pedaling rate at 50 rpm. The 
workload was adjusted to reach the participants’ heart 
rate at 50–60% of their heart rate reserved and was 
maintained at this level throughout the exercise period. 
The heart rate reserve was calculated by subtracting 
participants’ resting heart rate from their maximum 
heart rate with a formula of 220 minus age. The 
exercise intensity was confirmed with the Borg Scale 
for ratings of perceived exertion. It was expected that 
participants would rate the scale at 10 to 12 during 
the exercise period to indicate the moderate intensity 
of exercise. The use of these methods has been val-
idated and considered as a recommended approach 
for prescribing and monitoring exercise intensity in 
diabetic individuals [17].
The data collection was conducted on the exercise 
day with the support of two trained research assistants, 
two phlebotomists and one laboratory technician from 
a private clinical laboratory in Yogyakarta. The research 
assistants assessed participants’ blood pressure, heart 
rate, and perceptions of exertion. The research assis-
tants also ensured that participants adhered to the 
exercise protocol. Participants were required to take 
at least 10 hours overnight fast. The phlebotomists 
collected blood samples three times; (i) an hour after 
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a small standardized breakfast, prior to the ergocy-
cle exercise, (ii) within 5 minutes after the ergocycle 
exercise completed, and (iii) 30 minutes after the 
exercise. The blood samples were taken with a clean 
vein puncture (20-gauge needle) from an antecubital 
vein under controlled venous stasis of 40 torr for less 
than 30 seconds. All vein punctures were taken in a 
reclined position. 
Participants did not consume sugary drinks or food 
intake until the last blood sampling was performed. 
However, they could consume water or non-sugary 
drink, ad libitum, during the exercise and recovery 
period. Participants took their regular antidiabetic 
medication after the final blood sampling. Physicians 
were on site throughout the exercise and data collec-
tion period to monitor and ensure the safety aspect 
of the protocol, mainly for anticipating the signs of 
hypoglycemia that might occur.
Measures
Blood samples for the coagulation testing were 
prepared using citrate capillary with 3.2% sodium 
citrate and with a 1:10 dilution ratio to the specimen. 
Blood samples for other assessments were treated with 
EDTA. The complete methods for assessing the study 
outcomes and the corresponding normal reference 
range values are available in Table 1. 
In addition to prothrombin time, for each par-
ticipant, the international normalized ratio (INR) was 
calculated from the PT values according to standard 
practice. The data received from the laboratory tech-
nician were double-checked for ensuring the accuracy 
of the data. The range checks for data values were 
conducted and validated before the data were imported 
into a statistical program for analysis. 
Analysis
The feasibility aspect was assessed by observing the 
ability and willingness of the participants in adhering 
to the exercise and data collection protocol. Repeated 
measured one-way ANOVA (RM-ANOVA) was carried 
out to assess the differences of outcome measures over 
time before (T0), immediately after (T1) and 30 minutes 
(T3) after ergocycle exercise. The Shapiro Wilk test and 
the sphericity assumption using the Mauchly’s test were 
assessed. The Greenhouse-Geiser correction was used 
to interpret the within-subject effect for variables that 
did not meet the sphericity assumption. The pairwise 
comparisons using the Bonferroni post hoc test were 
explored if the within-subject effects were significant. 
Data were analysed using SPSS® v21.0 (SPSS Inc., Chi-
cago, IL, US). A P-value < 0.05 represented statistical 
significance. 
Results
Participants characteristics
Participants’ mean age was 64 ± 6.8, ranged from 
47 to 74 years old. Forty percent of participants were fe-
male, Fifty percent had education level up to secondary 
education while the rest had tertiary education. Sixty 
percent were unemployed or retired and 80 percent 
were married. None was ex-smoker or smoker. Seventy 
percent had been diagnosed as having T2DM for more 
than 5 years. Ninety percent received oral medication 
and only one participant received insulin therapy. The 
mean of blood glucose prior to the exercise and an 
hour after the standardized breakfast was 210 ± 130 
mg/dL. Most of them were also hypertensive with the 
mean of systole and diastole readings of 160 ± 20 and 
85 ± 15 mm Hg, respectively. Lastly, most of them were 
considered overweight with the average body mass 
index of 26 ± 4 kg/m2.
The feasibility of exercise and data collection 
protocol
All participants completed and adhered to the ergo-
cycle exercise procedure and the three data collection. 
Participants were able to maintain the exercise intensity 
at moderate levels based on the prescribed intensity 
which was assessed with % heart rate reserve and rating 
of perceived exertion throughout the exercise period. 
No incident and sign of hypoglycemia were reported 
by participants and the physician. There was no missing 
data for all outcome measures at the three time-point. 
Table 1. Study outcomes, instruments and normal refe-
rence range
Study  
outcomes
Methods/ 
/Formula
Normal  
reference range 
Coagulation parameters
Activated partial 
thromboplastin 
time 
Citrate plasma analysis 
with tromborel
23.0–30.2 second
Prothrombin 
time PT 
Citrate plasma analysis 
with actin and CaCl2
10.1–11.9 second
Platelets Hydrodynamic  
focussing 
150–440  
thousand/uL
Systemic inflammation
Erythrocytes 
sedimentation 
rate
Infrared sensor meth-
od with Westergreen 
value presentation
Male: 0–10 mm/hr
Female: 0–20 mm/hr
Blood glucose Spectrophotometry 
based on hexokinase 
method
< 110 mg/dL
PT — prothrombin time
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Outcome measures at baseline, immediately  
after and 30 minutes after ergocycle exercise
Figure 1 illustrates the ranges, interquartile, me-
dian and mean, while Table 2 summarizes the means 
and standard errors of the outcome measures before, 
immediately after and 30-minute post ergocycle exer-
cise, along with the results from the RM-ANOVA and 
post hoc analysis.
As shown in Table 2, all coagulant parameters 
increased immediately after the exercise. The values 
continued to increase during the recovery period except 
for platelet count which was the lowest at that period. 
Overall, these findings indicated a reduction in coag-
ulation activity. The erythrocytes sedimentation rates 
were unchanged before and after exercise, while the 
blood glucose steadily decreased immediately and 30 
minutes after exercise from the baseline value (< 0.01). 
Discussion
This study assessed the feasibility of the applica-
tion of a moderate intensity ergocycle exercise, among 
middle-aged and older T2DM patients to ensure the 
safety aspect of the exercise and study protocol. Our 
study demonstrated that the ergocycle exercise and 
Figure 1. Ranges, interquartile, median and mean of the outcome measures before, immediately after and 30-minute post 
ergocycle exercise 
30
29
28
27
26
25
24
Activated partial thromboplastin time
T0
T1
T2
12
12
11
11
10
10
9
9
8
Protrombin time
T0
T1
T2
450 000
400 000
350 000
300 000
250 000
200 000
150 000
Platelet 
T0
T1
T2
70
60
50
40
30
20
10
0
Erythrocyte sedimentation rate hour 1
T0
T1
T2
120
100
80
60
40
20
0
Erythrocyte sedimentation rate hour 2
T0
T1
T2
300
250
200
150
100
50
Blood glucose
T0
T1
T2
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study protocol was well-tolerated by middle-aged and 
older adults with T2DM. To our best knowledge, this 
present study is the first to report the effect of moder-
ate-intensity ergocycle exercise on clinical coagulation 
parameters and to explore the association of the co-
agulation parameters with systemic inflammation and 
blood glucose among T2DM patients. 
The most important clinically relevant findings 
of this present study were the elevation of aPTT and 
PT and the reduction of platelet counts that were 
observed after the short-term moderate-intensity 
ergocycle exercise, thus, indicated a tendency toward 
the improvement of coagulation. The findings were 
in consonance with a study that reported increases in 
aPTT, PT and fibrinolysis activities after vigorous exercise 
among diabetes patients [11]. However, the finding 
was in contrast with the increases in pro-coagulant 
activity that were reported among individuals with 
non-T2DM patients after short-term strenuous exercise 
testing [12]. Similarly, another study also reported the 
increased risk of thromboembolic incidents in running 
athletes after a prolonged vigorous exercise session 
[18]. These conflicting findings support the notion that 
the effect of exercise on the coagulation system varies 
and depends upon the exercise type, intensity, duration 
as well as different subjects’ medical conditions [13].
Although there were some variations of findings 
across previous studies, the absence of the transient 
hypercoagulation after a short moderate-intensity 
exercise in this present study was a significant finding 
because it highlights the safety aspect of the exercise 
among T2DM patients. The finding, however, needs to 
be interpreted with caution. The coagulation param-
eters of this study participants were still within the 
normal range throughout the study period. Thus, the 
increases of aPTT and PT as well as the reduction of 
platelet count in this study, although were statistically 
significant, may not be clinically significant. Also, the 
coagulation responses to the exercise on T2DM patients 
with impaired coagulation system may differ from our 
study participants with normal coagulation parame-
ters. Future studies, thus, need to further confirm the 
effect of the exercise on T2DM patients with impaired 
coagulation parameters. 
The increase of erythrocyte sedimentation rate 
(ESR), one of the systemic inflammation markers, 
among individuals with T2DM population has been 
reported [19], thus, the high baseline ESR values in 
this present study were expected. This present study, 
however, failed to demonstrate an improvement of ESR 
after a short-term moderate-intensity exercise. The find-
ing was in contrast with a recent study that reported 
improvements in ESR in individuals who engaged in 
regular moderate physical activity levels [20]. Chronic 
physiological adaptation may be required for ESR im-
provement. Also, the ESR is a non-specific inflammation 
marker that could be affected by conditions unrelated 
to T2DM such as aging, infections or malignancies [20]. 
Future studies, thus, should consider investigating the 
effect of both short- and long-term exercise programs 
on the systemic inflammation and take into account 
systemic inflammation markers mostly associated with 
T2DM conditions such as interleukin-6 and C-reactive 
protein [21].
Our study also demonstrated steady and significant 
improvement in blood glucose throughout the study 
period that was in line with the body of evidence that 
shows the positive effect of exercise in improving blood 
glucose levels [22, 23]. It has been recognized that ex-
ercise increases blood glucose utilization through the 
increased activity of the glucose transporter-4, which 
subsequently promotes the active muscle’s glucose 
uptake to supply the fuel for muscular activity [24]. 
The exercise also increases cell insulin sensitivity, which 
Table 2. The outcome measures before, immediately after and 30-minute post ergocycle exercise 
T0 T1 T2 p Post hoc 
Coagulation parameter
Activated partial thromboplastin time 
(second)
26.4 ± 0.5 26.8 ± 0.4 27.7 ± 0.4 0.01* T2 > T0, T2 > T1
Prothrombin time (second) 10.2 ± 0.3 10.5 ± 0.3 10.7 ± 0.2 0.03* T2 > T0
International normalized ratio 0.88 ± 0.02 0.90 ± 0.02 0.97 ± 0.03 0.01* T2 > T0
Platelet [thousand/ml] 262 ± 25 252 ± 24 249 ± 25 0.02* T2 < T0
Systemic inflammation
Erythrocytes sedimentation rate 1 [ml/hr] 27.0 ± 11.3 25.4 ± 9.3 30.4 ± 11.1 0.07# –
Erythrocytes sedimentation rate 2 [ml/hr] 47.3 ± 13.8 49.7 ± 12.4 50.4 ± 15.6 0.63 –
Blood glucose [mg/dL] 202 ± 35 173 ± 33 158 ± 30 < 0.01* T2 < T1 < T0
#Greenhouse-Geiser correction; *significant; T0 — baseline; T1 — within 5 minutes after ergocycle exercise; T2 — 30 minutes after ergocycle exercise
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stimulates blood glucose uptake via a separate channel 
[24]. These cumulative events eventually reduce the 
level of circulating blood glucose after the exercise. 
Lastly, although the blood glucose improvement 
in this present study was clinically significant, after 30 
minutes of recovery time, the blood glucose was still 
above the recommended level of 110 mg/dL [25]. Since 
further observations were not made after the 30-min-
ute period, a conclusion could not be drawn whether 
the blood glucose would continue to decrease and 
eventually achieved the recommended level after the 
study period. Herein, further studies are recommended 
to utilize the use of continuous glucose monitoring to 
confirm the magnitude, trend and duration of blood 
glucose improvement after exercise interventions are 
recommended. The information resulted from those 
studies will be required for assisting the T2DM patients 
in adjusting their exercise regimen and for guiding 
clinicians in prescribing anti-diabetic medication to 
achieve optimal glycemic control while avoiding hy-
poglycemia. 
The key strength of this study was the utilization of 
the recommended exercise principles for T2DM patients 
[25]. Thus, findings from this study could be directly 
applied to T2DM populations. This study has confirmed 
the feasibility aspect of the moderate-intensity ergo-
cycle exercise. The study also highlighted the safety 
aspect of the exercise and confirmed its potential role in 
improving hypercoagulation and blood glucose among 
middle-aged and adults with T2DM. The findings from 
this present study, however, must be interpreted in the 
context of certain limitations. First, this study was in-
tended to assess the feasibility of the exercise protocol 
and only used a small sample size, thus, it may have 
resulted in inadequate statistical power for detecting 
changes and associations in all parameters measured 
in this study. However, effect sizes could be approxi-
mated from this study for calculating the appropriate 
sample size for future studies. Second, the values of 
the coagulation parameters were still within the normal 
range at baseline, thus the findings of this study may 
not be generally applied for T2DM patients with im-
paired coagulation. Third, this study only explored the 
coagulation parameters and did not include the fibrino-
lytic parameters such as tissue plasminogen activator, 
plasminogen activator inhibitor-1, and d-dimer. For a 
complete interpretation of coagulation and fibrinolytic 
activities, future research is recommended to include 
these parameters. Last, the ESR that was used in this 
study is a nonspecific systematic inflammation marker. 
Thus, the use of systemic inflammation markers more 
related to T2DM pathogenesis such as CRP and IL-6 is 
recommended for future research. 
Conclusions
This study has shown that the short-term moderate- 
-intensity ergocycle exercise was well tolerated by 
middle-aged and older T2DM patients and resulted in 
improvements in coagulation parameters and blood 
glucose levels. The systemic inflammation characteri-
zed by the erythrocyte sedimentation rates, however, 
was unaffected. Future studies are recommended to 
investigate the chronic adaptation of the coagulation 
parameters after ergocycle training among T2DM pa-
tients with coagulation impairments.
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